Abbott Laboratories header image

Abbott Laboratories

ABT

Equity

ISIN null / Valor 903037

New York Stock Exchange, Inc (2026-11-06)
USD 109.93-3.23%

Abbott Laboratories
UMushroom community rating:

star star star star star
4.00 3 votes No rating yet
NegativeNeutralPositive

About company

Abbott Laboratories is a global healthcare company with a history spanning over 135 years, dedicated to improving lives through a wide range of healthcare products and technologies. With operations in more than 160 countries and a workforce of approximately 114,000 employees, Abbott focuses on major areas including cardiovascular care, diabetes care, diagnostics, neuromodulation, nutrition, and branded generic medicines. The company is known for its innovative solutions in managing health conditions, offering products like glucose monitoring systems that eliminate the need for painful fingersticks and technologies aimed at treating chronic pain and movement disorders. Abbott's commitment to healthcare innovation and its broad portfolio of products cater to the needs of consumers and healthcare professionals worldwide, aiming to make a lasting impact on global health.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-12.0%1Y
15.7%3Y
-11.6%5Y

Performance

27.2%1Y
22.8%3Y
23.1%5Y

Volatility

Market cap

190392 M

Market cap (USD)

Daily traded volume (Shares)

8,345,288

Daily traded volume (Shares)

1 day high/low

114.3 / 112.52

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

3 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.67
Society:
starstarstarstarstar
4.67
Nature:
starstarstarstarstar
4.33
Nathan Berhane
UK, 07 Nov 2026
star star star star star
Very promising
Ansh Saipratap Singh
UK, 29 Oct 2026
star star star star star
Great company to invest in with huge upside potential in upcoming quarters and their new researches and contribution in the field of medicine
William Phillips
UK, 22 Oct 2026
star star star star star
Promising

EQUITIES OF THE SAME SECTOR

Jubilant Pharmova Limited
Jubilant Pharmova Limited Jubilant Pharmova Limited Valor: 2477953
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%INR 938.60
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553360
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 101.00
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.70%EUR 85.26
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.57%USD 62.14
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%EUR 11.34
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.97%USD 69.74
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.62%USD 271.83
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.82%USD 23.40
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%EUR 6.32
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-13.06%EUR 0.55